Holen Sie sich die Stockscreener-App
3.83
0.26%
-0.010
Handel nachbörslich:
3.83
Schlusskurs vom Vortag:
$3.84
Offen:
$3.8
24-Stunden-Volumen:
61,939
Relative Volume:
0.86
Marktkapitalisierung:
$60.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.87M
KGV:
-0.1947
EPS:
-19.67
Netto-Cashflow:
$-47.63M
1W Leistung:
+11.34%
1M Leistung:
+14.84%
6M Leistung:
+34.39%
1J Leistung:
+19.69%
1-Tages-Spanne:
$3.59
$3.88
1-Wochen-Bereich:
$3.4021
$3.88
52-Wochen-Spanne:
$2.30
$3.93
Polypid Ltd Stock (PYPD) Company Profile
Vergleichen Sie PYPD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PYPD
Polypid Ltd
|
3.83 | 61.05M | 0 | -23.87M | -47.63M | -19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Polypid Ltd Stock (PYPD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-05 | Eingeleitet | Roth Capital | Buy |
| 2025-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2021-09-14 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-07-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-24 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2020-08-10 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-07-21 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-07-21 | Eingeleitet | Barclays | Overweight |
| 2020-07-21 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Polypid Ltd Aktie (PYPD) Neueste Nachrichten
Why PolyPid Ltd. stock could rally in 2025CEO Change & Momentum Based Trading Signals - newser.com
Is PolyPid Ltd. stock a contrarian buy2025 Technical Overview & Weekly Watchlist for Hot Stocks - newser.com
Is PolyPid Ltd. stock undervalued vs historical averagesRecession Risk & Fast Entry Momentum Trade Alerts - newser.com
Using data tools to time your PolyPid Ltd. exit2025 Winners & Losers & Long-Term Growth Plans - newser.com
Using flow based indicators on PolyPid Ltd.Jobs Report & Community Verified Watchlist Alerts - newser.com
How to build a custom watchlist for PolyPid Ltd.July 2025 Patterns & Stock Market Timing Techniques - newser.com
Published on: 2025-10-30 23:33:37 - newser.com
Why PolyPid Ltd. stock could benefit from AI revolutionQuarterly Trade Summary & Intraday High Probability Alerts - newser.com
Will PolyPid Ltd. stock outperform growth indexesAnalyst Downgrade & Community Verified Watchlist Alerts - newser.com
What makes PolyPid Ltd. stock attractive to growth fundsBond Market & Accurate Buy Signal Alerts - newser.com
Predicting PolyPid Ltd. trend using moving averages2025 Market Overview & Accurate Buy Signal Alerts - newser.com
PolyPid (NASDAQ: PYPD) to report third-quarter results Nov. 12; 8:30 a.m. ET - Stock Titan
How PolyPid Ltd. stock reacts to global recession fearsTrade Performance Summary & Long-Term Safe Investment Plans - Fundação Cultural do Pará
International - FinancialContent
Is PolyPid (NASDAQ:PYPD) A Risky Investment? - simplywall.st
Why PolyPid Ltd. stock remains resilientEarnings Summary Report & AI Enhanced Trading Signals - Fundação Cultural do Pará
Is PolyPid Ltd. stock reversal real or fakeJuly 2025 Review & Entry Point Confirmation Alerts - newser.com
Will PolyPid Ltd. stock reach all time highs in 2025July 2025 Sentiment & Fast Entry High Yield Stock Tips - Fundação Cultural do Pará
S P Trends: Will PolyPid Ltd. stock outperform growth indexesInflation Watch & Technical Pattern Recognition Alerts - Fundação Cultural do Pará
Weiss Ratings Reiterates Sell (E+) Rating for PolyPid (NASDAQ:PYPD) - MarketBeat
Finanzdaten der Polypid Ltd-Aktie (PYPD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):